RxDoctor Payments Data

Salia Campbell

Psychiatric/Mental Health · Jacksonville, FLNPI 1073294161

Payments from drug & device makers

$371in general payments, 2019–2025

Across 20 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$162
  • Teva Pharmaceuticals USA, Inc.$121
  • Gilead$34
  • Indivior Inc.$25
  • Otsuka America Pharmaceutical, Inc.$16
  • AbbVie$13

What the payments were for

  • Food & beverage$371100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$371 in reported general payments places this provider in the 35th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$168,097
Medicare patients
70
Services billed
10,311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate101$335,144
VraylarCariprazine Hcl70$102,771
Abilify MaintenaAripiprazole30$84,378
UzedyRisperidone16$39,092
RexultiBrexpiprazole13$19,484
Olanzapine OdtOlanzapine52$5,394
Quetiapine Fumarate176$3,715
Risperidone OdtRisperidone27$3,550
Benztropine Mesylate185$2,457
Ziprasidone Hcl42$2,337
Hydroxyzine Pamoate120$2,228
Doxepin Hcl34$2,192
Haloperidol Decanoate54$2,058
Olanzapine128$1,939
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine22$1,609

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$162$335,144101 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$16$103,86243 claims
AbbVieVraylar$13$102,77170 claims
Teva Pharmaceuticals USA, Inc.Uzedy$121$39,09216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →